Pharma Versus Biotech | GenomeWeb

Pharma Versus Biotech

Avalon Ventures' Kevin Kinsella tells Xconomy San Diego that big pharma's "predatory business practices are pushing the [biotech] sector almost to the point of extinction." Kinsella believes the pharmaceutical industry's practice could potentially be very detrimental to biotech firms, says Xconomy's Bruce Bigelow, adding that they may even be destructive to the entire drug development

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.